HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mozaffarian, D. Articles by Levy, W. C. Search for Related Content PubMed PubMed Citation Articles by Mozaffarian, D. Articles by Levy, W. C.

Anemia predicts mortality in severe heart failure

The prospective randomized amlodipine survival evaluation (PRAISE)

Dariush Mozaffarian, MD, MPH^*,*, Regina Nye, MPH and Wayne C. Levy, MD

^* Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA
Division of Cardiology, University of Washington, Seattle, USA
Pfizer PGRD, New London, Connecticut, USA

View larger version (17K): [in a new window]   Figure 1 Kaplan-Meier survival according to quintiles of hematocrit. *p = 0.004 for equality of survivor functions.

View larger version (16K): [in a new window]   Figure 2 Mortality rates according to deciles of hematocrit (Hct). Compared with the reference group (tenth decile, Hct >48.3%), higher mortality was only present in the first decile (Hct <35.4%), in which there was a 72% higher risk of death (hazard ratio 1.72, 95% confidence interval 1.13 to 2.62) after adjustment for potential confounders (Table 2, footnote).

View larger version (17K): [in a new window]   Figure 3 Mortality rates by cause of death, according to quintiles of hematocrit. Hematocrit was inversely associated with pump failure death (black bars) (p for trend <0.001). In contrast, there was a suggestion of a U-shaped relationship with sudden deaths (white bars) and other deaths (striped bars) (see text).